about
Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.New advances in musculoskeletal pain.Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsThe contribution of mitochondria to sensory processing and pain.Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy.Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.Peripheral neuropathy in a woman with breast cancer.Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.Characterization of a rat model of bortezomib-induced painful neuropathy.Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy.Observation of metal nanoparticles at atomic resolution in Pt-based cancer chemotherapeutics.Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.In vivo and in vitro effects of peripheral galanin on nociceptive transmission in naive and neuropathic statesNerve injury induces plasticity that results in spinal inhibitory effects of galaninNerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferentsMitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy
P50
Q30491771-56759137-C9AF-4E78-947A-C1D720EA2182Q34038073-D7E4C295-01D0-43AF-94C9-0FA094F98C1AQ35651995-33658F4E-45C6-478D-A9A9-D1023BE3A460Q35701568-CD944D3C-98DB-4825-8A07-7E46779F687EQ36571464-93AAFFDA-3A83-40E8-A311-D2BB22DEB2A6Q37170634-7074547E-7286-4F92-A6E9-19FAAAB0DA4EQ38368329-789E3C80-9511-4B46-8F91-71164EE3BA73Q39619975-0F8AAC4C-63A2-4B10-9995-F7537DEC72EAQ41184407-9001B28E-0B6C-4067-BAC3-5E648EF8B250Q42171790-8E0DE8DA-1ACD-4C93-BFC6-7FCF49002E5FQ44648418-879F6035-1A08-4EC5-A38B-868E82DB3CE6Q47120603-58A645AC-6602-47C5-8F84-E79B0AFA2577Q47232927-192D6909-C7B6-4360-88D1-770C1165638BQ48220263-463CCA0A-3F78-4A5A-B83B-A8FB7992488AQ52447938-350084DA-D63D-42F4-85FC-7197E75A6318Q55411583-C7B3D702-7360-4754-995F-C27A852A5DEEQ73080939-30CAC8E9-CF93-403E-A670-0A5F8FE29280Q74484821-1D840C67-5E13-42CC-B5C2-10A2C4D73386Q75336774-BD176F69-51BB-4A0E-A6B5-C18D320DA5B8Q92820584-551E496B-2552-4423-852F-64E84746127F
P50
description
researcher
@en
name
S J L Flatters
@en
S J L Flatters
@nl
type
label
S J L Flatters
@en
S J L Flatters
@nl
prefLabel
S J L Flatters
@en
S J L Flatters
@nl
P106
P31
P496
0000-0001-7129-3670